Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan-Apr;34(1):126-129.
doi: 10.4103/ipj.ipj_326_24. Epub 2025 Feb 6.

Fluoxetine brakes the menstrual cycle: Uncovering the unexpected effect

Affiliations

Fluoxetine brakes the menstrual cycle: Uncovering the unexpected effect

Barath Ramanathan et al. Ind Psychiatry J. 2025 Jan-Apr.

Abstract

Fluoxetine is one of the most commonly used antidepressants, classified under selective serotonin reuptake inhibitors (SSRIs). It is indicated for the treatment of depression, obsessive-compulsive disorder, anxiety, and eating disorders. The antidepressant effect of fluoxetine is achieved by inhibiting the reuptake of serotonin (5-HT) via the serotonin transporter (SERT) in neurons. Although fluoxetine is generally considered safe and well-tolerated by most patients, this case series describes instances where patients treated with fluoxetine subsequently developed menstrual irregularities. Upon discontinuation of fluoxetine, the menstrual cycles returned to normal. To the best of our knowledge, there is a lack of precise data associating fluoxetine with the onset of menstrual irregularities. This effect may be related to its central serotonergic action via 5-HT action modulates the prolactin, estradiol, and progesterone level. Therefore, physicians should be aware of the potential risk of fluoxetine-induced menstrual irregularities.

Keywords: Fluoxetine; SSRI; mensural irregularities.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

References

    1. Brambilla P, Cipriani A, Hotopf M, Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacopsychiatry. 2005;38:69–77. - PubMed
    1. Sohel AJ, Shutter MC, Patel P, Molla M. StatPearls [Internet] StatPearls Publishing; 2024. Fluoxetine. - PubMed
    1. Nicholas L, Dawkins K, Golden R. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am. 1998;21:341–58. - PubMed
    1. Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry. 1994;165:728–33. - PubMed
    1. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med. 2007;37:275–8. - PubMed

LinkOut - more resources